Overview of clinical use and side effect profile of valsartan in chinese hypertensive patients

Drug Design, Development and Therapy

Volumn 8, Issue , 2013, Pages 79-86

  Huang, Qi Fang ^a   Li, Yan ^a   Wang, Ji Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiotensin receptor blocker; Blood pressure; Efficacy; Hypertension; Side effect; Valsartan

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; HYDROCHLOROTHIAZIDE; NIFEDIPINE; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; TETRAZOLE DERIVATIVE; VALINE;

ANGIONEUROTIC EDEMA; BLOOD PRESSURE MEASUREMENT; CHINESE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HEMATURIA; HOT FLUSH; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; HYPOTENSION; MONOTHERAPY; MYALGIA; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERIPHERAL EDEMA; REVIEW; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VERTIGO; ANALOGS AND DERIVATIVES; CHINA; DRUG COMBINATION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; CHINA; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TETRAZOLES; VALINE;

EID: 84891587682     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S38617     Document Type: Review

References (30)

1. Writing Group of Chinese Guidelines for the Management of Hypertension. Preventive and therapeutic instruction of Chinese hypertension. Chinese Journal of Hypertension. 2000;8(2):103-112. Chinese.
2. Writing Group of Chinese Guidelines for the Management of Hypertension. [2004 update: Chinese guideline for prevention and treatment of patients with hypertension (practical edition)]. Zhonghua Xin Xue Guan Bing Za Zhi. 2004;32(12):1060-1064. Chinese.
3. Liu LS; Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579-615. Chinese.
4. Intercontinental Marketing Services (IMSHealth). Available from http://www.imshealth.com/portal/site/imshealth. Accessed December 11, 2013.
5. Zhu J-R, Fujita T, Shimamoto K, et al. Implication of clinical studies for the Asian population: focus on Chinese/Asian population. Int J Clin Pract. 2006;60(Suppl 150):14-16.
6. Zhang W, Li J. [Effects of valsartan on renal function in hypertensive patients]. South China Journal of Cardiology. 2005;11(1): 42-44. Chinese.
7. Ko GT, Tsang CC, Chan HC. Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: a one-year randomized study of valsartan versus enalapril. Adv Ther. 2005;22(2):155-162.
8. Li Q, Zhang Y. [Effects of valsartan and enalapril on hypertension and renal function in primary hypertensive patients]. Hebei Medical Journal. 2007;29(11):1211-1212. Chinese.
9. Zhang J, Chen S, Zhang S, Tao Z. [Efficacy and safety of olmesartan medoxomil in the treatment of essential hypertension]. Chinese Pharmacist. 2008;11(11):1351-1352. Chinese.
10. Li W, Chen X, Guan S, Xu Q, Wang B, Ke Q. [Comparison of olmesartan and valsartan in the treatment of middle aged primary hypertensive patients]. Clin Med Chin. 2009;25(7):704-705. Chinese.
11. Wang Y, Li Y, Sun N. [Effect of valsartan in the treatment of essential hypertension in male patients with erectile dysfunction]. Clin Med Chin. 2002;18(10):939-940. Chinese.
12. Huang M, Liu J, He X, et al. [Effects of valsartan on endothelial function in essential hypertension patients with atrial fibrillation]. Chinese Journal of Hypertension. 2007;15(2): 151-154. Chinese.
13. Cai J, Huang Z, Yang G, et al. Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy. Am J Cardiovasc Drugs. 2011;11(6):401-409.
14. Peng T, Hu Z, Guo L, et al. [Renal protective effects of benidipine and valsartan in primary hypertension patients with proteinuria]. Zhonghua Xin Xue Guan Bing Za Zhi. 2010;38(1):20-22. Chinese.
15. Liu L, Zhao SP, Zhou HN, Xu DY, Li JX. [Effect of valsartan on postprandial plasma inflammatory factors in patients with essential hypertension]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008;33(9): 809-813. Chinese
16. Yang T, Ma Q, Zeng X, et al. [Effects of valsartan or indapamide on sexual activity in middle-aged hypertensive men]. Chinese Journal of Hypertension. 2004;12(4):297-299. Chinese.
17. Sun NL, Wang HY, Zhu JR; Valsartan/HCTZ Clinical Investigation Group. [Therapeutic efficacy of valsartan and valsartan/HCTZ in mild to moderate hypertensive patients]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(8):715-718. Chinese.
18. Zhang S, Yu B, Li L, Du Z, Guan Z. Randomized, double-blinded trial evaluation of valsartan/hydrochlorothiazide combination therapy in mild to moderate essential hypertension in north-east China. J Int Med Res. 2008;36(4):630-637.
19. Ke YN, Huang J, Zhu JR; Valsartan/Amlodipine Single Pill Combination Study Group. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37(9):794-799. Chinese.
20. Wang JG, Zeng WF, He YS, et al; EXAM Investigators. Valsartan/amlodipine compared to nifedipine GITS in patients with hypertension inadequately controlled by monotherapy. Adv Ther. 2013;30(8): 771-783.
21. Ke YN, Dong YG, Ma SP, Yuan H, Ihm SH, Baek SH; ADVISE study group. Improved blood pressure control with nifedipine GITS/valsartan combination versus high-dose valsartan monotherapy in mild-to-moderate hypertensive patients from Asia: results from the ADVISE study, a randomized trial. Cardiovasc Ther. 2012;30(6): 326-332.
22. Guo LL, Li M, Wang AH. [Effects of benazepril and valsartan on erythropoietin levels in patients with essential hypertension]. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(10):1761-1763. Chinese.
23. Huang G, Chen K, Fang Y, Li W. [A case of first dose hypotension induced by usual dose of valsartan]. Journal of Gannan Medical College. 2005;25(1):99. Chinese.
24. Li B, Wei M, Zhang X, Liu X, Sheng S, Qiu C. [A case of angioedema induced by valsartan]. Herald of Medicine. 2004;23(10):782. Chinese.
25. Li J, Xiong A, Zhang Z. [A case of muscle pain induced by valsartan capsules]. World Clin Drugs. 2006;27(2):85. Chinese.
26. Zhang Z. [A misdiagnosed case of cough induced by valsartan]. Chinese Journal of Healthcare Medicine. 2008;10(5):328. Chinese.
27. Jiao W. [A case of urticaria, vertigo, infection of upper respiratory tract and muscle pain induced by long term use of valsartan]. Modern Journal of Integrated Traditional Chinese and Western Medicine. 2008;17(24):3843. Chinese.
28. Xu Q. [A case of hematuria induced by valsartan capsules]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease. 2009;17(9):806. Chinese.
29. Hua W, Zhou X. [A case of urticaria induced by valsartan]. Sichuan Med J. 2011;32(10):1662. Chinese.
30. Zhuang L. [A case of drug eruption caused by valsartan capsules]. Clinical Journal of Medical Officers. 2012;40(3):510. Chinese.